Conference Agenda

Registrations Opens

Delegates are requested to complete on-site registration and collect conference materials.

Cancer Diagnostics: From Cutting Edge to Daily Reality

Earlier and better diagnosis is fundamental to achieving improved cancer outcomes. Revolutionary technological advances such as liquid biopsies, genetic testing, and advanced imaging are transforming diagnostics.

This session also addresses challenges in clinical implementation, separating hype from reality, patient counseling, and evolving service models.

• Cancer screening, early detection & prevention
• Molecular diagnostics
• Personalized genomics & clinical biomarkers
• Digital cancer pathology and imaging
• Chemotherapy and biological therapeutics
• Innovational combinational therapies

Networking Break

Refreshments and networking with speakers, delegates, and industry experts.

Translational Oncology

Translational Oncology bridges basic research and clinical practice. Tumor heterogeneity, liquid biopsies, and immunotherapy play a vital role in advancing cancer care.

• Cellular and genetic oncology
• Bench-to-bedside laboratory concepts
• Cancer microenvironment
• Emerging cancer trends and opportunities
• Radiation oncology
• Global cancer market overview

Lunch & Networking Break

Lunch break with continued networking opportunities.

Anti-Cancer Drug Discovery

The global anticancer drug market is rapidly expanding due to increased cancer incidence, awareness, and R&D activities.

Key industry players include Roche, Pfizer, Novartis, AstraZeneca, Johnson & Johnson, Eli Lilly, Bayer, and others.

• New anti-cancer drug development
• Targeted drug delivery systems
• Plant-derived anticancer drugs
• Generic anti-cancer medicines
• Herbal and traditional medicine
• Alternative cancer therapeutics
• Quality control and standardization

Networking Break

Tea break and final networking session.

Cultural Events

Enjoy cultural performances showcasing local heritage and traditions.

Award Ceremony & Closing Ceremony

Recognition of outstanding contributions followed by official conference closure.